Archive: 05/02/2015

High-cost blood cancer drugs deliver high value

Amid the growing debate about the high price of powerful new drugs in the United States, a recent analysis suggests that breakthrough therapies for blood cancers may, in many cases and with some important caveats, provide ...

page 5 from 9